News Focus
News Focus
icon url

baulsdp

10/22/16 11:26 AM

#1147 RE: baulsdp #1146

And the difference between AMRI & IMNP is small. IMNP has a much better outlook on its future then AMRI did in its infant stage. AMRI made it on just one deal in the beginning, Allegra. IMNP has 7 promising drug canidates in various stages. If they all make it to the market their Patents will over lap keeping at least one drug in their sole rights for the next 15 to 20 years. Each patent has 10 yrs to keep generics out of the market and IMNP can collect that much more. You people need to Weiss up. Do your dd and wait for your investment to catch the crooks off guard.
icon url

Pharaoh-1

10/22/16 12:36 PM

#1148 RE: baulsdp #1146

Good morning, why don't u relax and take it easy?, this is a friendly discussion.

The market is the indication of the worthiness of any company. Right now, the market doesn't seem to believe in the company's survival. Who can change this? Not me, not you, and not the market, it is only the company who can change this by laying out a clear survival plan other than the intention of R/S. If this is the only solution they have, well, we will keep going down.